[18F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases. (2021)
Attributed to:
The NET-PDD study: defining the roles of NEuroinflammation and Tau aggregation in Parkinson's Disease Dementia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcab177
PubMed Identifier: 34485906
Publication URI: http://europepmc.org/abstract/MED/34485906
Type: Journal Article/Review
Volume: 3
Parent Publication: Brain communications
Issue: 3
ISSN: 2632-1297